In an era where technological advancements are reshaping the landscape of healthcare at an unprecedented pace, understanding where we’ve come from—and where we’re headed—has never been more critical. In this thought-provoking keynote, Darren Dasburg, a seasoned biopharma executive with over four decades of experience in technical operations, will take the audience on a journey through the evolution of therapeutic manufacturing: from the early days of synthetic molecules to the complex and highly personalized world of cell and gene therapies.

Drawing on his leadership roles across global pharmaceutical powerhouses and innovative biotech startups, Darren will explore the pivotal moments that have defined healthcare innovation - and how these milestones are informing the future.

Attendees will gain a unique perspective on how the U.S. is investing hundreds of billions into domestic manufacturing capacity and infrastructure, and why these investments are not just economic necessities, but ethical imperatives in ensuring timely, accessible therapies for patients.

The session will also address the growing urgency for digital maturity, operational readiness, and adaptive supply chains as precision medicine becomes the new standard.

Whether you're an executive, technologist, or Quality leader, Darren’s keynote will challenge assumptions, illuminate trends, and leave you with a clearer understanding of how the next wave of therapeutics will be delivered—and the critical role that American facilities will play in that future.